focus -WSS

focus

author：leisure time 2025-08-11 07:58:44 - browse：8

Rising drug prices —Medicare coverage from STAT — Medicare on Friday released new details about how its new drug price negotiation program will work, just two months before it’s set to start. APStock

WASHINGTON — Medicare on Friday released new details about how its new drug price negotiation program will work, just two months before it’s set to start.

Medicare released an initial outline of how the program will work in March. Some parts, including the outline of how drugs would be selected for the negotiation process, were immediately final. The agency asked drug companies, patients, and other affected parties to weigh in on other parts about how the process would proceed, what factors would be considered, and how drugmakers would be held accountable.

Newsletters

Sign up for D.C. Diagnosis

An insider's guide to the politics and policies of health care

Please enter a valid email address. Privacy Policy

The negotiation process was created last August in Democrats’ drug pricing reform law, and Medicare is supposed to select the first 10 drugs that will be subject to negotiation by Sept. 1.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： The strategy behind pharma's lawsuits over drug pricing reform

focus

knowledge

WSS

Health AI adoption puts security, privacy startups on investors' radar

App could help diagnose ear infections more accurately — and at home

Colonoscopy prep: Liquid

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

#NeedHerScience: shining a light on gender disparities in medicine

Weight bias in eating disorder treatment complicated by new weight loss drugs

hotspot

focus

Sign up for D.C. Diagnosis

knowledge

DIEP, the 'gold standard' of breast reconstruction, is under threat

The science behind Janet Jackson's pregnancy at 49

Bright Health sells Medicare Advantage business to Molina

New guidelines on severe brain injury complicate already difficult decisions

BioMarin wins approval for gene therapy to treat hemophilia A

UnitedHealth increases loan offers after Change Healthcare outage

State Dept. review finds Biden bears some blame for Afghanistan failures

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

As demand for Covid shots wanes, Moderna seeks its next success

Do masks work? RCTs can't tell us

Wikipedia

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

Health AI adoption puts security, privacy startups on investors' radar

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

Physicians and social media: If you see something, say something?

U.K. researchers warn about biases in medical devices, algorithms

Virtual Event: March of the Biosimilars

focus

knowledge

knowledge

Wikipedia